Xylanase, glucanase and xyloglucanase from Trichoderma citrinoviride DSM 33578 (4a39) for laying hens and piglets until 1 January 2036: three colorimetric methods on azurine substrates, 1500 EPU, 100 CU and 100 XGU/kg; batches had a ratio of about 7:1:1 instead of 15:1:1

Commission Implementing Regulation (EU) 2025/2503, published on 12 December 2025, authorises until 1 January 2036 a preparation of three enzymes produced by a non-genetically modified strain of Trichoderma citrinoviride DSM 33578 (holder: Huvepharma EOOD, product Huvezym® neXo) as a digestibility enhancer for poultry other than poultry for fattening and reared, and for pigs other than sows — those categories had already been authorised. After its opinions of 2022 and 2024, EFSA only in its opinion of 6 May 2025, based on new trials in laying hens and weaned piglets, considered the additive potentially efficacious in all poultry and all porcine species. The Polish title of the act reads “glwukanazy” (a typo).

Source: Rozporządzenie wykonawcze Komisji (UE) 2025/2503 z dnia 11 grudnia 2025 r. dotyczące zezwolenia na stosowanie preparatu endo-1,4-beta-ksylanazy, endo-1,4-beta-glukanazy i specyficznej dla ksyloglukanu endo-beta-1,4-glwukanazy wytwarzanych przy użyciu Trichoderma citrinoviride DSM 33578 jako dodatku paszowego dla drobiu innego niż drób rzeźny, drób odchowywany na nioski i w celach hodowlanych oraz dla gatunków świń innych niż lochy wszystkich gatunków świniowatych (posiadacz zezwolenia: Huvepharma EOOD)

Lab-News